Kantorberita.co.id – Jakarta, As many as 8 organizations of various professions today, Wednesday, November 2, 2022, held a press conference with the agenda to file a Class Action Lawsuit Against Pharmaceutical Manufacturers of Syrups Containing Hazardous Chemicals to the Supreme Court of the Republic of Indonesia.
Sunardjo Sumargono J as the coordinator of the plaintiff said, “Assalamualaikum Warahmatullahi Wabarokatuh, Rahayu, Shalom, Om Swastiastu Namo buddhaya, Best regards
We hereby, citizens of the Unitary Republic of Indonesia (NKRI) whose noble values are the nation’s
and Upholding the Value of Justice as fair as possible, in accordance with the mandate of the 2nd Precept,
and the 5th Precept, Pancasila. The magnitude of the ideals of the President of the Republic of Indonesia, Mr. Djoko Widodo, when he served as president for the first term, wanted legal reform, which so far has been like
poison left by the invaders, In the form of Law for Punishment, Should be Law for Justice, then today Wednesday
November 2, 2022, We are Merged from
- LPKN (National Consumer Protection Agency)
- POSBAKUM WICAKSANA (Wicaksana Legal Aid Post)
- KAI (Indonesian Advocates Congress)
- AWDI (Association of Indonesian Democratic Journalists)
- BEM FH UNIVERSITY JAKARTA
- INTERNATIONAL LEADHAM
- ROW OF MELLENIAL MOTHERS
- ASSOCIATION OF INDONESIAN ADVOCATE LAWYERS (HAPI)
Unite one mission to sue CLASS ACTION to the SUPREME COURT REPUBLIC OF INDONESIA, Considering that CLASS ACTION covers national (NKRI), not local.” He said in a press conference held on Jl. Ir. H. Juanda No. 4 A Gambir, Central Jakarta.
“We filed a lawsuit to the SUPREME COURT OF THE REPUBLIC OF INDONESIA against a pharmaceutical factory that produces syrups containing dangerous chemicals, resulting in kidney failure and/or death of the younger generation, especially the nation’s children. Therefore, it is obligatory to pay compensation to the government of the republic of Indonesia, Cq Minister of Finance, for all costs incurred in the context of treating or rehabilitating the nation’s children to the government of the Republic of Indonesia cq the Ministry of Finance of the Republic of Indonesia, amounting to Rp. 1,000,000,000,000 (one trillion rupiah) to be used the cost of medical and or rehabilitation costs for the victims, so that it is not the people and/or companies that do it, the government is responsible. (taxpayers who are charged with these costs). Therefore, THE SUPREME COURT OF THE REPUBLIC OF INDONESIA (MARI) as the Supreme Law Enforcement Agency is willing to ACCEPT AND EXAMINATE our lawsuit as fair as possible.” he continued.
Furthermore, the Director General of LPKN Prov DKI in relation to that proposed a Class Action, that the case of the people of the Republic of Indonesia vc pharmaceutical company is expected to help the government deal with the effects of drugs containing hazardous chemical elements which cause the young generation and/or children of Indonesia to experience and suffer from acute disease, the patient requires early treatment for kidney failure so that it can suppress the growth caused by syrup drugs containing these dangerous chemicals.
Class Action promoted by Sunardjo Sumargono, JD. together with the National Consumer Protection Agency, Posbakum, KAI, the International Human Rights Advocacy Institute, BEM FH UNIJA, AWDI, HAPI, and the Millennial Mothers Row is a form of public concern for other communities and to the State by filing Class Action lawsuits against pharmaceutical companies to the Supreme Court.
In the overall interest of the state (Indonesian people) it is hoped that the Supreme Court can examine and adjudicate this Class Action lawsuit, because this Class Action is not local in nature and can be tried by the Court of First Level and subsequently
Director General of the DKI Provincial Consumer Protection Agency, SUPRIYANTO, B.Ac., SH. MH. in his statement to the media crew said that regarding the case of the large public interest in responding to and responding to the actions of pharmaceutical companies that produce drugs containing hazardous chemical elements, this is a very positive attitude and is a form of concern that deserves appreciation from the government. RI.
It is hoped that considering this case is a very special and special case that has an impact on all levels of Indonesian society and is national and not just regional/regional, the Supreme Court can accept to examine and try this Class Action.
As we know, syrup medicines, including cough syrup and paracetamol syrup, are increasingly being highlighted when cases of mysterious acute kidney injury (AKI) or atypical progressive acute kidney disorders attack children.
This allegation began when there was a similar case in Gambia. In that country, dozens of children died of kidney failure after consuming paracetamol syrup made by Maiden Pharmaceutical Ltd, India.
The four cough medicines in question are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.
The Ministry of Health (Kemenkes) then investigated further allegations that led to acute kidney disorders with a number of parties, including the Food and Drug Supervisory Agency (BPOM), Epidemiologists, the Indonesian Pediatrician Association (IDAI), Pharmacologists, and the National Police Laboratory.
The Ministry of Health Instructs Pharmacies to Stop Selling Syrup Drugs Stop the syrup medicine Despite the absence of a definite cause, the Ministry of Health then issued instructions contained in Circular (SE) Number SR.01.05/III/3461/2022 concerning Obligations for Epidemiological Investigations and Reporting Cases of Atypical Acute Kidney Disorders ( Atypical Progressive Acute Kidney Injury) In Children.
In the letter, the ministry which is in charge of the health sector instructs medical personnel at health care facilities, including doctors, not to prescribe liquid medicine/syrup to patients.
Then, he instructed all pharmacies not to sell over-the-counter or limited-free drugs in liquid form for the time being to the public.
These restrictions are carried out until there is an official announcement from the government.
The instruction, which was signed by the Acting Director General of Health Services, Murti Utami, also asked parents who have children, especially toddlers, to temporarily refrain from taking over-the-counter medicines without advice from competent health workers.
“Treatment of sick children who suffer from fever at home prioritizes non-pharmacological management such as adequate fluid needs, warm water compresses, and wearing thin clothing,” the Ministry of Health’s instructions.
This instruction appeared on Wednesday (19/10/2022) morning, a day after the Indonesian Pediatrician Association (IDAI) advised to avoid giving cough medicine or paracetamol syrup to children.
IDAI asks parents to apply warm compresses first, considering that fever is the body’s way of fighting off incoming pathogens/viruses. The Ministry of Health also provides other alternatives.
Parents can replace syrup medicines with other medicines in the form of tablets, capsules, suppositories (anal), or others.
“The Ministry of Health urges the public to treat children, while not taking drugs in the form of liquid/syrup without consulting health workers,” said Ministry of Health spokesman Mohammad Syahril in a virtual press conference, Wednesday (19/10/2022).
(Dharma L/ Carlla)